J Clin Invest. 2024 May 15;134(10):e180795. doi: 10.1172/JCI180795.
Idiopathic systemic capillary leak syndrome (ISCLS) is a rare, recurrent condition with dramatically increased blood vessel permeability and, therefore, induction of systemic edema, which may lead to organ damage and death. In this issue of the JCI, Ablooglu et al. showed that ISCLS vessels were hypersensitive to agents known to increase vascular permeability, using human biopsies, cell culture, and mouse models. Several endothelium-specific proteins that regulate endothelial junctions were dysregulated and thereby compromised the vascular barrier. These findings suggest that endothelium-intrinsic dysregulation underlies hyperpermeability and implicate the cytoplasmic serine/threonine protein phosphatase 2A (PP2A) as a potential drug target for the treatment of ISCLS.
特发性全身性毛细血管渗漏综合征(ISCLS)是一种罕见的复发性疾病,其血管通透性显著增加,因此会引起全身性水肿,可能导致器官损伤和死亡。在本期 JCI 中,Ablooglu 等人通过人体活检、细胞培养和小鼠模型表明,ISCLS 血管对已知增加血管通透性的物质高度敏感。几种调节内皮细胞连接的内皮细胞特异性蛋白失调,从而破坏了血管屏障。这些发现表明,通透性增加的根本原因是内皮细胞内在失调,并暗示细胞质丝氨酸/苏氨酸蛋白磷酸酶 2A(PP2A)可能成为治疗 ISCLS 的潜在药物靶点。